ABVC Biopharma Inc share price logo

ABVC Biopharma Inc

NASDAQ: ABVC

Small Cap

$1.04

-0.01

(-0.95%)

as on

ABVC Biopharma Inc Stock Performance

as on May 6, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.02
    $1.09
    downward going graph

    1.92%

    Downside

    4.81%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.88
    $5.48
    downward going graph

    15.38%

    Downside

    426.92%

    Upside

    downward going graph

ABVC Biopharma Inc share price movements today

Previous Close
$1.05
Open
$1.08
Volume
291.1K
Day's Low - High
$1.02 - $1.09
52 Week Low - High
$0.88 - $5.48

ABVC Biopharma Inc Historical Returns

1 Month Return
-3.67 %
3 Month Return
-34.38 %
1 Year Return
-6.25 %
3 Year Return
-87.03 %
5 Year Return
0 %

ABVC Biopharma Inc Stock Fundamentals & Key Indicators

Check ABVC Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$26.4M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-7.1M

Revenue (TTM)

797.9K

Profit Margin

0.00%

Return On Equity TTM

-119.49%

ABVC Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ABVC Biopharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
ABVC Biopharma Inc image
ABVC Biopharma Inc
SELL$26.4MNANA0.00%
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.8B124.56%74.6712.55%
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$109.3B100.99%27.732.94%
BeiGene, Ltd. image
BeiGene, Ltd.
NA$33.0BNA118.865.37%
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$73.5B47.01%17.1229.65%

Stock Returns calculator for ABVC Biopharma Inc Stock including INR - Dollar returns

The ABVC Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

ABVC Biopharma Inc investment value today

Current value as on today

₹1,04,959

Returns

₹4,959

(+4.96%)

Returns from ABVC Biopharma Inc Stock

-₹7,143 (-7.14%)

Dollar Impact

₹12,101 (+12.1%)

Analyst Recommendation on ABVC Biopharma Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for ABVC Biopharma Inc. Average target price of $2.02

ABVC Biopharma Inc Share Price Target

Get share price movements and forecasts by analysts on ABVC Biopharma Inc.

What analysts predicted

48.51%UPSIDE

Target Price

$2.02

Current Price

$1.04

Analyzed by

6 Analysts

Target

$2.02

ABVC Biopharma Inc target price $2.02, a slight upside of 48.51% compared to current price of $1.04. According to 6 analysts rating.

ABVC Biopharma Inc Stock’s Investor Sentiment and Interest

Search interest for ABVC Biopharma Inc Stock has increased by 133% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:133% versus previous 30 day period

ABVC Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
0
0
0
0
0
0
0
-
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-2
-1
-2
0
0
0
0
-2
-1
-2
EBITDA
-2
-2
-2
0
0
-
0
-2
-1
-1
Interest Expense
1
1
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-3
-2
-1
0
0
0
-2
-1
-3
Income Tax Expense
0
0
-3
0
0
-
-
0
0
0
Net Income
-3
-3
-2
0
0
0
0
-2
-1
-3
Net Profit Margin
-20885.90%
-143692.10%
-235203.24%
-804.44%
-47.93%
11663.48%
-42831.89%
0.00%
-156.61%
447.63%

ABVC Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

Sep 2017
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
0
0
0
0
0
0
0
0
Gross Profit
-
0
0
0
0
0
0
0
0
0
Operating Income
-
-4
-2
-3
-8
-11
-15
-6
-4
-7
EBITDA
-
-4
-5
-3
-10
-10
-15
-6
-4
-6
Interest Expense
-
0
0
0
0
0
0
1
0
0
Depreciation
-
0
-
0
0
0
0
0
0
0
Income Before Tax
-
-4
-6
-4
-10
-11
-15
-8
-5
-8
Income Tax Expense
-
0
0
0
0
0
0
0
0
0
Net Income
-4
-4
-5
-3
-9
-12
-16
-7
-4
-7
Net Profit Margin
0.00%
-132755.32%
-80152.08%
-518.98%
-2026.97%
-3608.47%
-1693.50%
-5109.26%
-962.12%
-993.60%

ABVC Biopharma Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
0
-2
0
0
0
0
-2
-1
4
Operating Cash Flow
0
0
0
0
0
0
0
0
0
Investing Cash Flow
0
-
0
-
-
-
0
-1
0
Financing Cash Flow
0
0
0
0
0
0
1
1
1
Change in Cash
0
0
0
0
0
0
0
0
0

ABVC Biopharma Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-6
-4
-3
-10
-12
-16
-7
-5
-7
Operating Cash Flow
-1
0
-3
-4
-7
-7
-4
-1
-2
Investing Cash Flow
-7
0
0
0
0
-1
0
-
-1
Financing Cash Flow
9
0
3
9
9
4
3
1
4
Change in Cash
0
0
0
4
1
-5
0
0
0

Global Institutional Holdings in ABVC Biopharma Inc

Funds
Holdings
Tower Research Capital LLC
0.01%
SIMPLEX TRADING, LLC
0%
Millennium Management LLC
0.08%
Northwestern Mutual Wealth Management Co
0%
UBS Group AG
0.01%
See all

Insights on ABVC Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, ABVC Biopharma Inc has experienced a drawdown of -87.0%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 80.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 17.5% return, outperforming this stock by 23.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, ABVC stock has moved down by -34.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 795.95K → -795.95K (in $), with an average decrease of 200.0% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -1.24M → -3.56M (in $), with an average decrease of 185.8% per quarter

About ABVC Biopharma Inc

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus, which is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer; ABV-2001, an intraocular irrigation solution; ABV-2002, a corneal Storage Solution; and ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer. The company has a co-development agreement with Rgene Corporation and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California.
OrganisationABVC Biopharma Inc
Headquarters44370 Old Warm Springs Boulevard, Fremont, CA, United States, 94538
IndustryBiotechnology
CEODr. Uttam Yashwant Patil Ph.D.
E-voting on sharesClick here to vote

Key Management of ABVC Biopharma Inc

Name

Title

Mr. Eugene Jiang

Chairman & Chief Business Officer

Dr. Uttam Yashwant Patil Ph.D.

CEO & Interim CFO

Dr. Tsung-Shann Jiang EMBA, Ph.D.

Chief Scientific Officer, Chief Strategy Officer & Director

FAQs

What is ABVC Biopharma Inc share price today?

ABVC Biopharma Inc share price today is $1.04 as on at the close of the market. ABVC Biopharma Inc share today touched a day high of $1.09 and a low of $1.02.

What is the 52 week high and 52 week low for ABVC Biopharma Inc share?

ABVC Biopharma Inc share touched a 52 week high of $5.48 on and a 52 week low of $0.88 on . ABVC Biopharma Inc stock price today i.e. is closed at $1.04,which is 81.02% down from its 52 week high and 18.17% up from its 52 week low.

What is ABVC Biopharma Inc's market capitalisation today?

ABVC Biopharma Inc market capitalisation is $0.00T as on .

How to invest in ABVC Biopharma Inc Stock (ABVC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ABVC Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ABVC Biopharma Inc Shares that will get you 1.4423 shares as per ABVC Biopharma Inc share price of $1.04 per share as on May 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy ABVC Biopharma Inc Stock (ABVC) from India?

Indian investors can start investing in ABVC Biopharma Inc (ABVC) shares with as little as ₹95.28 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in ABVC Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on ABVC Biopharma Inc share’s latest price of $1.04 as on May 6, 2026 at 1:29 am IST, you will get 9.6154 shares of ABVC Biopharma Inc. Learn more about fractional shares .